Iconovo has developed a new and innovative dry powder inhaler platform – ICOpre – aimed for a global market. ICOpre is a pre-metered dry powder inhaler for simple, once-daily treatment, containing 30 individually sealed doses.

Hear dr Orest Lastow, founder and CTO at Iconovo, tell the story about the development process and business opportunities ICOpre enables.

Iconovo deltar på Stockholm Corporate Finance 13e Life Science Seminarium den 23 mars 2021, kl. 11.00 då VD Johan Wäborg presenterar senaste utvecklingen och framtiden för bolaget. Stockholm Corporate Finance arrangerar kapitalmarknadsdagen för trettonde året i rad. Om du vill anmäla dig som deltagare till kapitalmarknadsdagen så använd denna länk,

Iconovo AB (publ) has been granted its first patent in India on the inhalation platform ICOone®. Iconovo has previously granted ICOone® patents in Europe (EPO) and have several patents pending in USA, India, China and Japan.

ICOone® is Iconovo’s platform for simple and cost-efficient delivery of vaccines and biomolecules to the lung. Since ICOone® delivers a dry powder, there is no need for expensive and complicated cold storage. Inhaling the drug eliminates the use of disposable syringes and no hazardous waste with blood contaminated syringes is generated.

A good example of ICOone® use is the cooperation with Monash University. In this project Oxytocin is administered to women during birth to prevent heavy bleeding, Postpartum Hemorrhage (PPH). Oxytocin is today typically delivered as an injection and requires cold storage, which can be very challenging in regions with less developed infrastructure. PPH is globally the most common cause of maternal mortality with over 60 000 fatalities annually. India represents a significant part of all PPH cases.

”A patent in India is extremely important for us since it is a large potential market for which ICOone® is particularly well suited. A cheap, simple and safe way to supply vaccines to a large population is of great interest to many of our potential customers, not the least in India”, says Dr. Orest Lastow, CTO and founder at Iconovo.

About ICOone®
ICOone® is a unique, patented dry powder inhaler for single use. The smart design generates an ultra-low manufacturing cost combined with simple and discreet use. It is particularly suitable for short-term treatment and as-needed use as it provides an unsurpassed low treatment cost and price point for treatments with a low number of doses. The simple design also enables patients and caregivers to learn how to handle the inhalers with minimal training. ICOone® can deliver large inhalation doses that are well protected against moisture, an important factor for many biomolecules.



Iconovos VD Johan Wäborg intervjuas av aktieanalytiker Johan Löchen från Erik Penser Bank. Se videon youtu.be.



Inhalationsbolaget Iconovo har idag publicerat bokslutskommunikén för 2020 som visar högre omsättningssiffror jämfört med året innan. Under 2020 lyckades bolaget teckna två nya kundavtal och målet är att ingå ytterligare två kundavtal under 2021. Se videon på BioStock.



Bolagspresentation av Iconovo från Aktiedagen den 27 januari 2021.


Iconovo kommer under kvartalet att delta på följande events och där presentera bolaget.

Aktiespararna – Aktiedagen Lund

Presentation Iconovo Onsdag 27 januari kl. 10.15-10.45

Datum: 27 och 28 januari 2021
Tid: 08.00-21.00
Plats: Digital, livestreaming via webb

Anmälningar via Hemsida/website: https://www.aktiespararna.se/aktiviteter/aktiedagen-lund-digitalt
Vi streamar live och on demand via Aktiespararnas YouTube-kanal samt via aktiespararna.se

Swiss Nordic Bio

Datum: 10 och 11 februari 2021
Tid: 09.00-18.00
Plats: Digital, livestreaming via webb


Stockholm Corporate Finance 13:e Life Science-seminarium 

Stockholm Corporate Finance bjuder in investerare, analytiker och finansmedia till det trettonde årliga Life Science-seminariumet i samarbete med Financial Hearings. Moderator under dagarna är Charlotte Stjerngren, partner Cord Communications.

Datum: 23 och 24 mars 2021
Tid: 07.30-12.15
Plats: Digital, livestreaming via webb

Klicka på nedanstående länk för att anmäla dig till seminariumet.
Anmälning via: https://www.lyyti.fi/reg/scf-life-science-seminarium-2021

On January 27,  we will participate and present Iconovo at Aktiedagen Lund.

Production information

Location: Elite Hotel Ideon, Scheelevägen 27, Lund

Recording: Wednesday 27th January, 08:00am – 09:00pm

Website: https://www.aktiespararna.se/aktiviteter/aktiedagen-lund-digitalt


It will be broadcasted live and on demand through Aktiespararna YouTube-Channel and aktiespararna.se

Aktiedagen Lund 210127

CEO Johan Wäborg – Iconovo company presentation and Q&A att the BioStock Life Science Summit 2020.

See the presentation

Iconovos VD Johan Wäborg intervjuas av Pensers Bank efter Q3 rapporten den 27 oktober 2020.

Se intervjun här